Abstract
The formulation of monoclonal antibodies, antibody drug conjugates, fusion proteins, and enzymes for administration typically requires lyophilization to maintain biologic activity. The control of pH throughout the lyophilization process is critical to maintaining biologic activity and an acceptable shelf life. In this chapter, the critical aspects of selecting a buffer that achieves optimal stability throughout the freeze-drying process and on subsequent storage are presented. Acidic and basic components that can be used to moderate pH to maintain the therapeutic activity of biological molecules during processing by lyophilization are reviewed. Throughout this chapter we focus on what properties of the buffer are important for achieving acceptable stability in both the solution and dry states, and minimizing the potential for pH changes that may accompany temperature changes and freeze concentration throughout the lyophilization process. One critical attribute of the buffer system is potential for crystallization during freeze concentration. The potential for crystallization of different buffers is highlighted in this chapter, including the role that other components in the formulation, such as sugars, can either promote or retard buffer crystallization. It was further demonstrated that freeze-drying can result in significant changes in apparent acidity even without buffer crystallization. The changes in the apparent acidity, which were monitored by measuring ionization of probe molecules and expressed as Hammett acidity function, depend both on buffer type and co-solutes (such as sugars and polymers) and were shown to correlate with degradation rates of acid-sensitive compounds. The chapter concludes with a case study that illustrates the criticality of selecting the appropriate buffer system to achieving a stable formulation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akers MJ, Milton N, Byrn SR, et al. Glycine crystallization during freezing: the effects of salt form, pH, and ionic strength. Pharm Res. 1995;12:1457–61.
Alkhamis KA. Influence of solid-state acidity on the decomposition of sucrose in amorphous systems. Int J Pharm. 2008;362(1–2):74–80.
Bates RJ. Revised standard values for pH measurements from 0 to 95 C. J Res Natl Bureau Stand-A. Phys Chem. 1962;66 A.
Bates RG. Determination of pH: theory and practice. New York: Wiley; 1973. p. 222.
Bell LN, Labuza TP. Compositional influence on the pH of reduced-moisture solutions. J Food Sci. 1992;57:732–4.
Bottari E, Festa MR. Equilibrium analysis: amino acids as ligands of cations. Current Topics Anal Chem. 2004;4:155–88.
Burcusa MR. Excipient phase behavior in the freeze-concentrate. Dissertation, University of Minnesota; 2013.
Cavatur RK, Suryanarayanan R. Characterization of frozen aqueous solutions by low temperature X-ray powder diffractometry. Pharm Res. 1998;15:194–99.
Chang L, Pikal M. Mechanisms of protein stabilization. J Pharm Sci. 2009;98:2886–908.
Chang BS, Randall CS. Use of subambient thermal analysis to optimize protein lyophilization. Cryobiology. 1992;29:632–56.
Chatterjee K. Chemical reactivity and physical stability of lyophilized solids. Dissertation, University of Minnesota; 2004.
Chatterjee K, Shalaev EY, Suryanarayanan R, Govindarajan R. Correlation between chemical reactivity and the Hammett acidity function in amorphous solids using inversion of sucrose as a model reaction. J Pharm Sci. 2008;97(1):274–86.
Croyle M, Roessler BJ, Davidson BL, et al. Factors that influence stability of recombinant adenoviral preparations for human gene therapy. Pharm Dev Technol. 1998;3:373–83.
Eriksoon JHC, Hinrichs WLJ, de Jong GL, et al. Investigations into the stabilization of drugs by sugar glasses: III. The influence of several high pH buffers. Pharm Res. 2003;20:1437–43.
Flynn GL. Buffers-pH Control within Pharmaceutical Systems. J Parenteral Drug Assoc. 1980;34:139–62.
Forney-Stevens K. Extending the shelf-life of lyophilized protein formulations: amino acids as stabilizers and early detection of amorphous phase separation. Dissertation, University of Connecticut; 2013.
Gana FZ, Rashid I, Badwan A, Alkhamis KA. Determination of solid-state acidity of chitin-metal silicates and their effect on the degradation of cephalosporin antibiotics J Pharm Sci. 2012;101(7):2398–407.
Gokarn YR, et al. In: Katdare A, Chaubal M, editors. Excipients development for pharmaceutical, biotechnology and drug delivery systems. Informa Healthcare USA, Inc.; 2006. pp. 291–331.
Gomez G. Crystallization-related pH changes during freezing of sodium phosphate buffer solutions. Dissertation, University of Michigan; 1995.
Gomez G, et al. Effect of initial buffer composition on pH changes during far-from equilibrium freezing of sodium phosphate buffer solution. Pharm Res. 2001;18:90–7.
Govindarajan R, Chatterjee L, et al. Impact of freeze-drying on ionization of sulfonephthalein probe molecules in trehalose-citrate systems. J Pharm Sci. 2006;95:1498–510.
Hailu SA, Bogner RH. Solid-state surface acidity and pH-stability profiles of amorphous quinapril hydrochloride and silicate formulations. J Pharm Sci. 2010;99(6):2786–99.
Hammett LP. The theory of acidity. J Am Chem Soc. 1928;50:2660–74.
Kolhe P, Amend E, Singh SK. Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation. Biotechnol Prog. 2010;26:727–33.
Lam XM, Constantino HR, Overcashier DE, et al. Replacing succinate with glycolate buffer improves the stability of lyophilized interferon-gamma. Int J Pharm. 1996;14:285–95.
Larseen SS. Studies on stability of drugs in frozen solutions. VI. The effect of freezing upon pH for buffered aqueous solutions. Arch Pharm Chem Sci Ed. 1973;1:41–53.
Li J, Chatterjee K, Medek A, et al. Acid-base characteristics of bromophenol blue-citrate buffer systems in the amorphous state. J Pharm Sci. 2004;93:697–712.
Lu E, Ewing S, Gatlin L, Suryanarayanan R, Shalaev EY. The effect of bulking agents on the chemical stability of acid-sensitive compounds in freeze-dried formulations: sucrose inversion study. J Pharm Sci. 2009;98(9):3387–96.
Mathlouthi M, Reiser P, editors. Sucrose: properties and applications. Springer Publishing; 1995. p. 241.
Milton N, Nail S. The crystallization of kinetics of glycine hydrochloride from “frozen” solution. Cryo-Lett. 1997;18:335–42.
Murase N, Franks F. Salt precipitation during the freeze concentration of phosphate buffer solutions. Biophys Chem. 1989;34:293–300.
Murase N, Echlin P, Franks F. The structural states freeze concentrated and freeze-dried phosphates studied by scanning electron-microscopy and differential scanning calorimetry. Cryobiology. 1991;28:364–75.
Orii Y, Morita M. Measurement of the pH of frozen buffer solutions by using pH indicators. J Biochem. 1977;81:163–8.
Osterberg T, Wadsten T. Physical state of L-histidine after freeze-drying and long-term storage. Eur J Pharm. 1999;273:85–93.
Osterberg T, Fatouros A, Mikaelsson M. Development of freeze-dried albumin-free formulation of recombinant factor VIII. Pharm Res. 1997;14:892–8.
Pikal-Cleland KA, et al. Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer system. J Pharm Sci. 2002;91:1969–79.
Pyne A, Chatterjee K, Suryanarayanan R. Crystalline to amorphous transition of disodium hydrogen phosphate during primary drying. Pharm Res. 2003;20:802–03.
Remmele R, Jr, Krishnan S, Callahan, W. Development of stable lyophilized protein drug products. Curr Pharm Biotech. 2012;13:471–96.
Shalaev EY. The impact of buffer on processing and stability of freeze-dried dosage forms. Part. 1 Solution freezing behavior. Am Pharm Res. 2005;8:80–7.
Shalaev EY, Franks F. Solid-liquid state diagrams in pharmaceutical lyophilization: crystallization of solutes. In: Levine H, editor Progress in amorphous food and pharmaceutical systems. The Royal Society of Chemistry; 2002. pp. 200–15.
Shalaev EY, Gatlin LA. The impact of buffer on solid-state properties and stability of freeze-dried dosage forms. In: Jameel F, Hershenson S, editors. Formulation and process development strategies for manufacturing biopharmaceuticals. Willey; 2010. pp. 507–20.
Shalaev EY, Kanev AN. Solid-liquid state diagram of the water-glycine-sucrose system. Cryobiology. 1994;31:374–82.
Shalaev EY, Johnson-Elton T, Chang L, et al. Thermophysical properties of pharmaceutically compatible buffers at sub-zero temperature: implications for freeze drying. Pharm Res. 2002;19:195–291.
Sundaramurthi P, Suryanarayanan R. The effect of crystallizing and non-crystallizing cosolutes on succinate buffer crystallization and consequent pH shift in frozen solutions. Pharm Res. 2011;28:374–85.
Sundaramurthi P, Suryanarayanan R. Calorimetry and complementary techniques to characterize frozen and freeze-dried systems. Adv Drug Del Rev. 2012;64:384–95.
Sundaramurthi P, Shalaev E, Suryanarayanan R. “pH Swing” in frozen solutions-consequence of sequential crystallization of buffer components. J Phys Chem Lett. 2010;1:265–68.
Van den Berg L. pH changes in buffers and foods during freezing and subsequent storage. Cryobiology. 1966;3:236–42.
Van den Berg L, Rose D. The effect of addition of sodium and potassium chloride to the reciprocal system: KH2PO4-Na2HPO4-H2O on pH and composition during freezing. Arch Biochim Biophys. 1959a;84:305–15.
Van den Berg L, Rose D. Effects of freezing on the pH and composition of sodium and potassium solutions: reciprocal system KH2PO4-Na2HPO4-NaH2PO4-H2O. Arch Biochim Biophys. 1959b;81:319–29.
Varshney DB, Kumar S, Shalaev EY, et al. Glycine crystallization in frozen and freeze-dried systems: effect of pH and buffer concentration. Pharm Res. 2007;24:593–604.
Varshney DB, Sundaramurthi P, Kumar K, et al. Phase transitions in frozen systems and during freeze-drying: quantification using synchrotron x-ray diffractometry. Pharm Res. 2009;26:1596–606.
Wang W. Lyophilization and development of solid protein pharmaceuticals. Intl J Pharm. 2000;203:1–60.
Zarubina SA, Kryukov PA, Shuvaev AV. pH of tris-buffer solution in sea water at temperatures 273–298.15 K and pressures 0,1–58,8 mPa. Izvestiya Sibirskogo Otdeleniya Akademii Nauk SSSR. Seriya Khimicheskikh Nauk. 1988;2:88–94.
Acknowledgments
We would like to thank Roger Kimball, Renuka Reddy, Julie Luppkie, and Joanne Lukaszewicz (Pfizer Inc.) for the stability data, and Drs. Ramprakash Govindarajan and Raj Suryanarayayan for measuring the Hammett acidity function as reported in the “Case Study” section.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wu, C., Shamblin, S., Varshney, D., Shalaev, E. (2015). Advance Understanding of Buffer Behavior during Lyophilization. In: Varshney, D., Singh, M. (eds) Lyophilized Biologics and Vaccines. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2383-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2383-0_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2382-3
Online ISBN: 978-1-4939-2383-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)